Back
Eyenovia 10K Form
Sell
21
EYEN
Eyenovia
Last Price:
0.11
Seasonality Move:
42.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EYEN News And Ratings
See the #1 stock for the next 7 days that we like better than EYEN
EYEN Financial Statistics
Sales & Book Value
| Annual Sales: | $3.79K |
|---|---|
| Cash Flow: | $-5.95M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.04 |
| Price / Book: | 2.5 |
Profitability
| EPS (TTM): | -0.71000 |
|---|---|
| Net Income (TTM): | $-37.83M |
| Gross Margin: | $0 |
| Return on Equity: | -676.86% |
| Return on Assets: | -143.72% |
Eyenovia Earnings Forecast
Key Eyenovia Financial Ratios
- The Gross Profit Margin over the past 5 years for EYEN is 0.00%.
- The Selling, General & Administrative Expenses for EYEN have been equal to 327,984.70% of Gross Profit Margin.
- The Research & Development expenses have been 342,370.18% of Revenue.
- The Interest Expense is -8.70% of Operating Income.
- The Net Earning history of EYEN is -719,290.24% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Eyenovia Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EYEN |
| CUSIP: | 30234E |
| Website: | eyenovia.com |
Debt
| Debt-to-Equity Ratio: | 3.11 |
|---|---|
| Current Ratio: | 0.74 |
| Quick Ratio: | 0.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |